{"DataElement":{"publicId":"7487187","version":"1","preferredName":"Laboratory Procedure Baseline Prostate Specific Antigen Measurement Outcome Status","preferredDefinition":"A response used to verify the status of the prostate specific antigen level present in a sample obtained at baseline.","longName":"7487186v1.0:7487359v1.0","context":"ECOG-ACRIN","contextVersion":"1","DataElementConcept":{"publicId":"7487186","version":"1","preferredName":"Laboratory Procedure Baseline Prostate Specific Antigen Measurement Outcome","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._A starting point to which things may be compared._The determination of the prostate specific antigen present in a sample._The result of an action.","longName":"2543047v1.0:7487184v1.0","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"2543047","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2262D258-9F2F-4D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7487184","version":"1","preferredName":"Baseline Prostate Specific Antigen Measurement Outcome","preferredDefinition":"A starting point to which things may be compared.:The determination of the prostate specific antigen present in a sample.:The result of an action.","longName":"C25213:C17634:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Baseline","conceptCode":"C25213","definition":"A starting point to which things may be compared.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Prostate Specific Antigen Measurement","conceptCode":"C17634","definition":"The determination of the prostate specific antigen present in a sample.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B31545C6-9350-6F03-E053-4EBD850AB5FE","latestVersionIndicator":"Yes","beginDate":"2020-11-01","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-11-01","modifiedBy":"ONEDATA","dateModified":"2020-11-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B31545C6-9361-6F03-E053-4EBD850AB5FE","latestVersionIndicator":"Yes","beginDate":"2020-11-01","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-11-01","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeDescription":"Created for EA8183, 11/01/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7487359","version":"1","preferredName":"PSA Result Status","preferredDefinition":"A condition or state at a particular time.","longName":"7487359v1.0","context":"ECOG-ACRIN","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Detectable but PSA level less than 0.2 ng/mL","valueDescription":"Detectable PSA Level Less than 0.2","ValueMeaning":{"publicId":"7487183","version":"1","preferredName":"Detectable PSA Level Less than 0.2","longName":"7487183","preferredDefinition":"The capability of being noticed, identified or discovered.: A blood concentration of prostate specific antigen less than 0.2 ng/mL.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Detectable","conceptCode":"C111567","definition":"The capability of being noticed, identified or discovered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"PSA Level Less than 0.2","conceptCode":"C142109","definition":"A blood concentration of prostate specific antigen less than 0.2 ng/mL.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3150639-B1D1-6F00-E053-4EBD850ABA4E","latestVersionIndicator":"Yes","beginDate":"2020-11-01","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-11-01","modifiedBy":"ONEDATA","dateModified":"2020-11-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2E8F057-8B92-7D4F-E053-4EBD850AC48B","beginDate":"2020-11-02","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-11-02","modifiedBy":"ONEDATA","dateModified":"2020-11-02","deletedIndicator":"No"},{"value":"Detectable and PSA level greater than or equal to 0.2 ng/mL","valueDescription":"Detectable And PSA Level Greater than or Equal to 0.2","ValueMeaning":{"publicId":"7487358","version":"1","preferredName":"Detectable And PSA Level Greater than or Equal to 0.2","longName":"7487358","preferredDefinition":"The capability of being noticed, identified or discovered.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: A blood concentration of prostate specific antigen greater than or equal to 0.2 ng/mL.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Detectable","conceptCode":"C111567","definition":"The capability of being noticed, identified or discovered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"PSA Level Greater than or Equal to 0.2","conceptCode":"C138952","definition":"A blood concentration of prostate specific antigen greater than or equal to 0.2 ng/mL.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B314EB3E-665C-6F07-E053-4EBD850A09C0","latestVersionIndicator":"Yes","beginDate":"2020-11-02","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-11-02","modifiedBy":"ONEDATA","dateModified":"2020-11-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2E8F057-8B9C-7D4F-E053-4EBD850AC48B","beginDate":"2020-11-02","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-11-02","modifiedBy":"ONEDATA","dateModified":"2020-11-02","deletedIndicator":"No"},{"value":"Undetectable","valueDescription":"Undetectable","ValueMeaning":{"publicId":"4119838","version":"1","preferredName":"Undetectable","longName":"4119838","preferredDefinition":"The inability to be noticed, identified or discovered.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Undetectable","conceptCode":"C111568","definition":"The inability to be noticed, identified or discovered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F11FE908-073E-ACC7-E040-BB89AD431787","latestVersionIndicator":"Yes","beginDate":"2014-01-29","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-01-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2E8F057-8BA6-7D4F-E053-4EBD850AC48B","beginDate":"2020-11-02","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-11-02","modifiedBy":"ONEDATA","dateModified":"2020-11-02","deletedIndicator":"No"},{"value":"Detectable, PSA level greater than 0 but less than 0.2 ng/mL","valueDescription":"Detectable PSA Level Greater Than 0 but Less Than 0.2","ValueMeaning":{"publicId":"7794852","version":"1","preferredName":"Detectable PSA Level Greater Than 0 but Less Than 0.2","longName":"7794852","preferredDefinition":"The capability of being noticed, identified or discovered.: A blood concentration of prostate specific antigen greater than 0 and less than 0.2 ng/mL.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Detectable","conceptCode":"C111567","definition":"The capability of being noticed, identified or discovered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"PSA Level Greater than 0 but Less than 0.2","conceptCode":"C182129","definition":"A blood concentration of prostate specific antigen greater than 0 and less than 0.2 ng/mL.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD9F3E5F-0D10-2EF4-E053-4EBD850ABE44","latestVersionIndicator":"Yes","beginDate":"2021-10-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-10-05","modifiedBy":"ONEDATA","dateModified":"2021-10-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CD9F45EB-465B-4A84-E053-4EBD850A6588","beginDate":"2021-10-05","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-10-05","modifiedBy":"ONEDATA","dateModified":"2021-10-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2404650","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"005AD6E5-057F-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2E8F057-8B7C-7D4F-E053-4EBD850AC48B","latestVersionIndicator":"Yes","beginDate":"2020-11-02","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-11-02","modifiedBy":"GARRIDOJ","dateModified":"2021-10-05","changeDescription":"Created for EA8183, 11/2/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3314482","version":"1","longName":"Type of Category","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"6013685","version":"1","longName":"Stratification Factor","context":"ECOG-ACRIN"},{"publicId":"3314494","version":"1","longName":"Labs","context":"ECOG-ACRIN"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Baseline PSA","type":"Preferred Question Text","description":"Baseline PSA","url":null,"context":"ECOG-ACRIN"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B31564BC-509D-6EFE-E053-4EBD850A9C56","latestVersionIndicator":"Yes","beginDate":"2020-11-01","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2020-11-01","modifiedBy":"GARRIDOJ","dateModified":"2021-03-08","changeDescription":"Created for EA8183, 11/01/2020 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}